scholarly article | Q13442814 |
P356 | DOI | 10.3892/OL.2016.4153 |
P8608 | Fatcat ID | release_u3tsyhuzwnhd7pbikvsdpry36y |
P932 | PMC publication ID | 4774572 |
P698 | PubMed publication ID | 26998077 |
P5875 | ResearchGate publication ID | 292073994 |
P50 | author | Wei-An Chang | Q82048273 |
P2093 | author name string | Po-Lin Kuo | |
Ya-Ling Hsu | |||
Ying-Ming Tsai | |||
Shah-Hwa Chou | |||
Jen-Yu Hung | |||
Ming-Shyan Huang | |||
Hung-Hsing Chiang | |||
P2860 | cites work | Flavonoids--food sources and health benefits | Q27000031 |
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib | Q27824829 | ||
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways | Q28274882 | ||
Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines | Q28275084 | ||
NCI-Navy Medical Oncology Branch cell line supplement | Q28299547 | ||
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells | Q28480805 | ||
Cancer statistics, 2009 | Q29547625 | ||
Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non‐small cell lung cancer | Q33194582 | ||
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma | Q34073766 | ||
The critical DNA damage by benzo(a)pyrene in lung tissues of smokers and approaches to preventing its formation | Q34110681 | ||
Benzo pyrene-induced DNA adducts and gene expression profiles in target and non-target organs for carcinogenesis in mice | Q34402066 | ||
Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer | Q34526893 | ||
Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas | Q34567984 | ||
Metabolite profiling of grape: Flavonols and anthocyanins | Q34568995 | ||
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations | Q35023498 | ||
Tumor microenvironment: a new treatment target for cancer | Q35361431 | ||
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer | Q35671213 | ||
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer | Q35671281 | ||
Hydrophobic flavonoids from Scutellaria baicalensis induce colorectal cancer cell apoptosis through a mitochondrial-mediated pathway | Q36623138 | ||
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients | Q36785938 | ||
Pleural effusion in lung cancer: more questions than answers | Q38009999 | ||
Flavonoids from Gynostemma pentaphyllum exhibit differential induction of cell cycle arrest in H460 and A549 cancer cells | Q38943210 | ||
Benzo(a)pyrene promotes A549 cell migration and invasion through up-regulating Twist | Q38993113 | ||
Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression | Q39509528 | ||
Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1. | Q39830464 | ||
Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma | Q40141195 | ||
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma | Q42771554 | ||
Missense mutations of the BRAF gene in human lung adenocarcinoma. | Q44235698 | ||
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients | Q46685665 | ||
Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway | Q47753819 | ||
Flavonol profiles of Vitis vinifera red grapes and their single-cultivar wines. | Q50707154 | ||
Differential carcinogenicity of benzo[a]pyrene in male and female CD-1 mouse lung | Q50939221 | ||
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. | Q51428264 | ||
Somatic mutations in human cancer: insights from resequencing the protein kinase gene family | Q79995343 | ||
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models | Q80352305 | ||
Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression | Q86965859 | ||
P433 | issue | 3 | |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 1783-1790 | |
P577 | publication date | 2016-01-26 | |
P1433 | published in | Oncology Letters | Q20640514 |
P1476 | title | Laricitrin suppresses increased benzo(a)pyrene-induced lung tumor-associated monocyte-derived dendritic cell cancer progression | |
P478 | volume | 11 |
Q37709119 | Laricitrin ameliorates lung cancer-mediated dendritic cell suppression by inhibiting signal transducer and activator of transcription 3 |
Q41694323 | The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer |